Continuing the Conversation | Optimizing Care for Patients With Endometrial Cancer: A Focus on Pharmacist Interventions and Mitigation of Health Equit...

· Recognize the role of biomarker expression in the selection of most appropriate treatment options for patients with endometrial cancer · Review strategies for identification and management of drug-related toxicities in patients receiving therapy with immune checkpoint inhibitors, targeted agents, or combination therapy Faculty: Sarah Hayward, PharmD, BCOP Clinical Pharmacy Specialist, Gynecologic Oncology Stephenson Cancer Center at OU Health University of Oklahoma Health Science Center Oklahoma City, Oklahoma Sarah Hayward, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Consultant (advisory board): GSK, Seagen/Genmab Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-322-H01-P. The activity is available for CE credit through June 30, 2023. This educational activity is supported by an educational grant from GlaxoSmithKline Learn more about your ad choices. Visit megaphone.fm/adchoices